Strategising template-guided needle placement for MR-targeted prostate biopsy

TL;DR

This paper presents a reinforcement learning approach to optimize template-guided needle placement in MR-targeted prostate biopsies, improving accuracy and adaptiveness over traditional methods.

Contribution

It introduces a patient-specific RL policy for prostate biopsy targeting, outperforming baseline strategies and adapting to lesion size without hand-engineered rewards.

Findings

Achieved 93% hit rate in prostate cancer targeting

RL strategies adapt to lesion size, prioritizing needle spread for smaller lesions

Outperformed human-designed baseline strategies in accuracy and efficiency

Abstract

Clinically significant prostate cancer has a better chance to be sampled during ultrasound-guided biopsy procedures, if suspected lesions found in pre-operative magnetic resonance (MR) images are used as targets. However, the diagnostic accuracy of the biopsy procedure is limited by the operator-dependent skills and experience in sampling the targets, a sequential decision making process that involves navigating an ultrasound probe and placing a series of sampling needles for potentially multiple targets. This work aims to learn a reinforcement learning (RL) policy that optimises the actions of continuous positioning of 2D ultrasound views and biopsy needles with respect to a guiding template, such that the MR targets can be sampled efficiently and sufficiently. We first formulate the task as a Markov decision process (MDP) and construct an environment that allows the targeting actions to be performed virtually for individual patients, based on their anatomy and lesions derived from MR images. A patient-specific policy can thus be optimised, before each biopsy procedure, by rewarding positive sampling in the MDP environment. Experiment results from fifty four prostate cancer patients show that the proposed RL-learned policies obtained a mean hit rate of 93% and an average cancer core length of 11 mm, which compared favourably to two alternative baseline strategies designed by humans, without hand-engineered rewards that directly maximise these clinically relevant metrics. Perhaps more interestingly, it is found that the RL agents learned strategies that were adaptive to the lesion size, where spread of the needles was prioritised for smaller lesions. Such a strategy has not been previously reported or commonly adopted in clinical practice, but led to an overall superior targeting performance when compared with intuitively designed strategies.